Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of BioClinica, Inc. in Connection with the Sale of the Company to JLL Partners, Inc.

BIOCQ
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of BioClinica, Inc. in Connection with the Sale of the Company to JLL Partners, Inc.

NEW YORK, Feb. 1, 2013 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of BioClinica, Inc. ("BioClinica" or the "Company") (NasdaqGM: BIOC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to a holding company controlled by JLL Partners, Inc.

(Logo:  http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Click here to learn how to join the action: http://zlk.9nl.com/bioclinica-bioc/, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, BioClinica shareholders will receive $7.25 for each share of BioClinica stock they own. The investigation concerns whether the BioClinica Board of Directors breached their fiduciary duties to BioClinica stockholders by failing to adequately shop the Company before entering into this transaction and whether JLL Partners, Inc. is underpaying for BioClinica shares, thus unlawfully harming BioClinica stockholders. In particular, at least one analyst set a price target for BioClinica stock at $9.00 per share.

If you own common stock in BioClinica and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, http://zlk.9nl.com/bioclinica-bioc/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (866) 367-6510
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today